Recovering from head and neck cancer means addressing both physical and emotional needs. With the right care, compassion, and ...

Every year, 72,680 people across the U.S. – or 199 people per day – receive a cancer diagnosis of the oral cavity, pharynx or ...

About one-third of head and neck squamous cell cancer (HNSCC) survivors who have undergone radiation therapy (RT) are ...

Low-dose computed tomography is more sensitive than chest radiography in diagnosing lung metastases of second primary lung cancer in HNSCC survivors.

Q1 2025 Earnings Call Transcript May 12, 2025 Coherus BioSciences, Inc. misses on earnings expectations. Reported EPS is ...

Hoss joins a distinguished group of patrons, including HRH Princess Michael of Kent, Cher, Lord Digby Jones of Birmingham, Dr ...

At the upcoming ASCO Annual Meeting, we will present another Phase 1b clinical update on our PRAME cell therapy, IMA203, in ...

This Sunday is Mother’s Day, a time to celebrate the women we love. It’s also the perfect moment to have an important ...

Phenotypic variables such as smoking history and occupational exposures were significators predictors of head and neck cancer risk.

Learn the critical warning signs that distinguish between ordinary neck pain and potentially serious conditions requiring ...

A recent study published in Engineering has shed new light on the mechanisms underlying the metastasis of head and neck squamous cell carcinoma (HNSCC).

Immutep's eftilagimod shows a 17.6-month survival benefit in head and neck cancer. Find out how and why IMMP is continuing to ...